SynthesisInternational journal of colorectal disease2021

KRAS mutation is predictive for poor prognosis in rectal cancer patients with neoadjuvant chemoradiotherapy: a systemic review and meta-analysis.

Junfu Peng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.